Policy Lab

This report attempts to understand the implications of price controls on the early-stage life science industry.

This report attempts to better understand the potential effect of price-setting policies such as H.R.3 on pharmaceutical innovation.

This report examines proposed changes to Part D from the lens of the early-stage life science research ecosystem.